COPENHAGEN - Ascendis Pharma A/S (NASDAQ: ASND) shares gained 2.9% after the biopharmaceutical company reported a narrower-than-expected second-quarter loss and revenue that exceeded analyst estimates ...

QNRX READ THE FULL QNRX RESEARCH REPORT FDA clears initiation of 2nd NS pivotal whole body clinical study for QRX003, CL-QRX003-002 Quoin Pharmaceuticals (NASDAQ:QNRX) reported 2Q25 results today and ...

Net loss per share (GAAP) was $0.62, but remained negative as the company continues to invest heavily in research and development. The pivotal Phase 2 trial for Danon disease was placed on clinical ...

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

The issue with placing it on the floodplain is that it reduces the available area for floodwaters to spread out and slow down,” one neighbor said.

MSU is pausing a 'transition of psychiatric services for students,' apparently in response to pushback to layoffs of staff ...

Wessex, which missed out on the devolution priority programme, has announced a number steps locally to lay the groundwork for ...

A Cordova Mall restaurant was temporarily closed during its latest inspection after an inspector found rodent droppings, live roaches and dead roaches.

The Indoor Football League acknowledged there was a judgment error by officials in the review process on the last play of the Rattlers' 49-48 playoff loss to the San Diego Strike Force on Aug. 4 at ...

I tested Google's Gemini AI for two months to see if it could boost my output and transform my daily routine. My boss and my ...

High-speed internet projects are one step closer to reality in nine rural Santa Barbara County communities following the completion ...